Risk assessment of radionecrosis rates following stereotactic radiosurgery or radiotherapy of brain metastases using the "Equivalent Uniform Dose"

Risk assessment of radionecrosis rates following stereotactic radiosurgery or radiotherapy of brain metastases using the "Equivalent Uniform Dose" - EUDSRS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034131

Enrollment

200

Registered

2024-12-30

Start date

2023-04-25

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79.3

Interventions

Group 1: Retrospective Analysis of Patients with brain metastases who received cranial stereotactic radiosurgery or hypofractionated stereotactic radiotherapy between 2017 and 2024.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: brain metastases stereotactic radiotherapy or radiosurgery

Exclusion criteria

Exclusion criteria: Prior whole brain radiotherapy

Design outcomes

Primary

Measure	Time frame
Radiation Necrosis, diagnosed by an experianced neuroradiologist by using follow-up MRIs.	—

Secondary

Measure	Time frame
Local Control, as time between stereotactic radiosurgery and lokcal recurrence of the irradiated metastases.	—

Countries

Germany

Contacts

Public ContactMaximilian Niyazi

LMU Klinikum München

maximilian.niyazi@med.uni-muenchen.de089 4400 73770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026